ChemicalBook > CAS DataBase List > Afatinib Impurity 77
Afatinib Impurity 77
- Product Name
- Afatinib Impurity 77
- CAS No.
- 26404-20-6
- Chemical Name
- Afatinib Impurity 77
- Synonyms
- Afatinib Impurity 77;propan-2-yl 2-chloro-2-oxoacetate;chloroglyoxylicacidisopropylester;chlorooxoacetic acid isopropyl ester;Acetic acid, 2-chloro-2-oxo-, 1-methylethyl ester
- CBNumber
- CB55475022
- Molecular Formula
- C5H7ClO3
- Formula Weight
- 150.56
- MOL File
- 26404-20-6.mol
More
Less
Afatinib Impurity 77 Property
- Boiling point:
- 145-147 °C
- Density
- 1.173 g/cm3
Afatinib Impurity 77 Preparation Products And Raw materials
Raw materials
Preparation Products
More
Less
Afatinib Impurity 77 Suppliers
- Tel
- 0371-55900031 18137872243
- Fax
- QQ:2853979815
- 2853979815@qq.com
- Country
- China
- ProdList
- 10007
- Advantage
- 55
- Tel
- +86-400-002-6226 +86-13028896684;
- sales@rrkchem.com
- Country
- China
- ProdList
- 57423
- Advantage
- 58
- Tel
- 2710913286@.com
- 1513643261@qq.com
- Country
- China
- ProdList
- 14246
- Advantage
- 58
- Tel
- 400-168-9330 15013243073
- 597760450@qq.com
- Country
- China
- ProdList
- 2942
- Advantage
- 58
- Tel
- 15071299552
- Fax
- QQ:262933239
- 262933239@qq.com
- Country
- China
- ProdList
- 6887
- Advantage
- 58
- Tel
- 18576690171 17386083646
- 3001006472@qq.com
- Country
- China
- ProdList
- 11837
- Advantage
- 58
- Tel
- +86-027-59232304 15387063101
- 2881924050@qq.com
- Country
- China
- ProdList
- 9959
- Advantage
- 58
- Tel
- 18989489206
- hongxipharm@163.com
- Country
- China
- ProdList
- 4880
- Advantage
- 58
- Tel
- 13417589054 13417589054
- trendseenbio@gmail.com
- Country
- China
- ProdList
- 9470
- Advantage
- 58
- Tel
- 027-027-16602739303 16602739303
- 673003916@qq.com
- Country
- China
- ProdList
- 2964
- Advantage
- 58
More
Less
View Lastest Price from Afatinib Impurity 77 manufacturers
ShenZhen H&D Pharmaceutical Technology Co., LTD
- Product
- Afatinib impurity 77
- Price
- US $0.00-0.00/mg
- Min. Order
- 10mg
- Purity
- 98%
- Supply Ability
- 500mg
- Release date
- 2024-06-04